UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 44

Sortiert nach

Icosabutate, a More Potent Form of Omega 3 Fatty Acids, Shows Promise in Lowering Triglycerides

Cardiology, 2016-01, Vol.135 (1), p.1-2

Riesen, Walter F.

2016

Volltextzugriff (PDF)

Performance evaluation of the Access FT3 and FT4 assays, comparison with Immulite and AxSym, and the relationship to TSH values

Clinical laboratory (Heidelberg), 2012-01, Vol.58 (7-8), p.645

2012

Volltextzugriff (PDF)

Commentary to factors predicting cardiovascular events in statin-treated diabetic and non-diabetic patients with coronary atherosclerosis (1)

Atherosclerosis, 2010-02, Vol.208 (2), p.332-333

Riesen, Walter F

2010

Volltextzugriff (PDF)

Treat-to-target versus dose-adapted statin treatment of cholesterol to reduce cardiovascular risk

European journal of preventive cardiology, 2016-02, Vol.23 (3), p.275-281

2016

Volltextzugriff (PDF)

Statin-induced immunomodulatory effects on human T cells in vivo

Atherosclerosis, 2004-07, Vol.175 (1), p.83-90

2004

Volltextzugriff (PDF)

Pleiotropic Effects of Statins - What Is Their Clinical Significance?

Praxis (Bern. 1994), 2022-02, Vol.110 (2), p.86

Riesen, Walter F

2022

Volltextzugriff (PDF)

A new view of arteriosclerosis development points the way to new therapy concepts

Praxis (Bern. 1994), 2016-04, Vol.105 (8), p.427

Riesen, Walter F

2016

Volltextzugriff (PDF)

2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk

European heart journal, 2020-01, Vol.41 (1), p.111-188

2020

Volltextzugriff (PDF)

Toward a more professional and practical medical education: a novel Central European approach

Advances in medical education and practice, 2015-01, Vol.6 (default), p.459-467

2015

Volltextzugriff (PDF)

Heparinized blood provides equivalent results to EDTA in the CEDIA and FPIA cyclosporine immunoassays, thus facilitating routine cyclosporine determination

Clinica chimica acta, 2008-04, Vol.390 (1), p.138-140

2008

Volltextzugriff (PDF)

Lipid-lowering therapy: strategies for improving compliance

Current medical research and opinion, 2004-01, Vol.20 (2), p.165-173

2004

Volltextzugriff (PDF)

CRP measured by a high sensitivity assay correlates with clinical probability (Wells score) testing for deep venous thrombosis

Thrombosis and haemostasis, 2004-04, Vol.91 (4), p.841

2004

Volltextzugriff (PDF)

Comparability of Serum and Plasma Concentrations of Haemostasis Activation Markers

Clinical chemistry and laboratory medicine, 2001-07, Vol.39 (7), p.627-630

2001

Volltextzugriff (PDF)

Elevation of the serum total and free prostate-specific antigen levels after stent implantation in patient with coronary artery disease

Swiss medical weekly, 2009-11, Vol.139 (45-46), p.646

Riesen, W F

2009

Volltextzugriff (PDF)

Statin treatment in primary and secondary prevention--a statement

Revue médicale suisse, 2014-12, Vol.10 (455), p.2430

2014

Volltextzugriff (PDF)

Acid-base and endocrine effects of aldosterone and angiotensin II inhibition in metabolic acidosis in human patients

The Journal of laboratory and clinical medicine, 2000-11, Vol.136 (5), p.379-389

2000

Volltextzugriff (PDF)

What are the biomarkers of atherosclerosis and cardiovascular risk?

Revue médicale suisse, 2008-03, Vol.4 (148), p.636

Riesen, Walter F

2008

Volltextzugriff (PDF)

New european guidelines for dyslipidemia

Revue médicale suisse, 2012-03, Vol.8 (331), p.525

2012

Volltextzugriff (PDF)

Effect of thyroid function on concentrations of lipoprotein(a)

Clinical chemistry (Baltimore, Md.), 1993-12, Vol.39 (12), p.2466

1993

Volltextzugriff (PDF)

Increased Lipoprotein(a) levels are not a steady prothrombotic defect

Blood, 2001-09, Vol.98 (6), p.1993-1994

2001

Volltextzugriff (PDF)

Herbert Keller January 16, 1925 June 25, 2001

Clinical chemistry and laboratory medicine, 2001-01, Vol.39 (9)

2001

Volltextzugriff (PDF)

Herbert KellerJanuary 16, 1925 June 25, 2001

Clinical chemistry and laboratory medicine, 2001-09, Vol.39 (9), p.783-783

2001

Volltextzugriff (PDF)

The Current View on Hypercholesterolemia after the ‘Heart Protection Study’ – Do We Need New Strategies?

Heart drug, 2002, Vol.2 (4), p.201-203

Riesen, Walter F.

2002

Volltextzugriff (PDF)

Variable region sequence of the light chain from a Waldenstroem's IgM with specificity for phosphorylcholine

Biochemistry (Easton), 1976-08, Vol.15 (17), p.3829-3833

1976

Volltextzugriff (PDF)

Beneficial metabolic effects of insulin-like growth factor I in patients with severe insulin-resistant diabetes type A

European journal of endocrinology, 1994-09, Vol.131 (3), p.251

1994

Volltextzugriff (PDF)

1 – 25 von 44

Suche als RSS-Feed

Aktive Filter

ThemaMiddle Aged

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(40)
Mit Volltextzugriff
(32)

Publikationsform

Artikel
(44)

Sprache

Erscheinungsjahr

n.n

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Icosabutate, a More Potent Form of Omega 3 Fatty Acids, Shows Promise in Lowering Triglycerides

Performance evaluation of the Access FT3 and FT4 assays, comparison with Immulite and AxSym, and the relationship to TSH values

Commentary to factors predicting cardiovascular events in statin-treated diabetic and non-diabetic patients with coronary atherosclerosis (1)

Treat-to-target versus dose-adapted statin treatment of cholesterol to reduce cardiovascular risk

Statin-induced immunomodulatory effects on human T cells in vivo

Pleiotropic Effects of Statins - What Is Their Clinical Significance?

A new view of arteriosclerosis development points the way to new therapy concepts

2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk

Toward a more professional and practical medical education: a novel Central European approach

Heparinized blood provides equivalent results to EDTA in the CEDIA and FPIA cyclosporine immunoassays, thus facilitating routine cyclosporine determination

Lipid-lowering therapy: strategies for improving compliance

CRP measured by a high sensitivity assay correlates with clinical probability (Wells score) testing for deep venous thrombosis

Comparability of Serum and Plasma Concentrations of Haemostasis Activation Markers

Elevation of the serum total and free prostate-specific antigen levels after stent implantation in patient with coronary artery disease

Statin treatment in primary and secondary prevention--a statement

Acid-base and endocrine effects of aldosterone and angiotensin II inhibition in metabolic acidosis in human patients

What are the biomarkers of atherosclerosis and cardiovascular risk?

New european guidelines for dyslipidemia

Effect of thyroid function on concentrations of lipoprotein(a)

Increased Lipoprotein(a) levels are not a steady prothrombotic defect

Herbert Keller January 16, 1925 June 25, 2001

Herbert KellerJanuary 16, 1925 June 25, 2001

The Current View on Hypercholesterolemia after the ‘Heart Protection Study’ – Do We Need New Strategies?

Variable region sequence of the light chain from a Waldenstroem's IgM with specificity for phosphorylcholine

Beneficial metabolic effects of insulin-like growth factor I in patients with severe insulin-resistant diabetes type A

Aktive Filter

Suchergebnisse filtern